Prospects for SARS-CoV-2 diagnostics, therapeutics and vaccines in Africa

E Margolin, WA Burgers, ED Sturrock… - Nature Reviews …, 2020 - nature.com
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
resulted in a global pandemic, prompting unprecedented efforts to contain the virus. Many …

COVID-19 preparedness: capacity to manufacture vaccines, therapeutics and diagnostics in sub-Saharan Africa

B Bright, CP Babalola, NA Sam-Agudu… - Globalization and …, 2021 - Springer
Objective The COVID-19 pandemic is a biosecurity threat, and many resource-rich countries
are stockpiling and/or making plans to secure supplies of vaccine, therapeutics, and …

SARS-CoV-2: Virology, epidemiology, immunology and vaccine development

M Baay, B Lina, A Fontanet, A Marchant, M Saville… - Biologicals, 2020 - Elsevier
Abstract This first International Alliance for Biological Standardization Covid-19 webinar
brought together a broad range of international stakeholders, including academia …

[HTML][HTML] COVID-19: Progress in diagnostics, therapy and vaccination

X Liu, C Liu, G Liu, W Luo, N Xia - Theranostics, 2020 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has recently become a pandemic. As the sudden …

[HTML][HTML] Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines

HI Shih, CJ Wu, YF Tu, CY Chi - Biomedical journal, 2020 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19) pandemic caused by a novel
coronavirus, SARS-CoV-2, has infected more than 22 million individuals and resulted in …

Fast-track development of vaccines for SARS-CoV-2: the shots that saved the world

VP Chavda, Q Yao, LK Vora, V Apostolopoulos… - Frontiers in …, 2022 - frontiersin.org
In December 2019, an outbreak emerged of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) which leads to coronavirus disease 2019 (COVID-19). The World Health …

[HTML][HTML] Development of vaccines for SARS-CoV-2

WH Ng, X Liu, S Mahalingam - F1000Research, 2020 - ncbi.nlm.nih.gov
COVID-19 emerged in late 2019 and has rapidly spread through many countries globally.
The causative SARS-CoV-2 virus was not known until recently, and there is little or no …

[HTML][HTML] COVID-19 vaccines development in Africa: a review of current situation and existing challenges of vaccine production

E Lamptey, EK Senkyire, DA Benita… - Clinical and …, 2022 - ncbi.nlm.nih.gov
Following the development of the coronavirus disease 2019 (COVID-19) vaccines and the
launching of vaccination, the World Health Organization has reported that the African …

Characterization of the first SARS-CoV-2 isolates from aotearoa New Zealand as part of a rapid response to the COVID-19 pandemic

R Harfoot, B Lawley, LC Hernández, J Kuang, J Grant… - Viruses, 2022 - mdpi.com
SARS-CoV-2, the virus responsible for the COVID-19 pandemic, has wreaked havoc across
the globe for the last two years. More than 300 million cases and over 5 million deaths later …

The early landscape of coronavirus disease 2019 vaccine development in the UK and rest of the world

HR Sharpe, C Gilbride, E Allen… - …, 2020 - Wiley Online Library
Summary Since the first World Health Organization notification on 31 December 2019,
coronavirus disease 2019 (COVID‐19), the respiratory disease caused by the coronavirus …